CS Mitsiades (2005) “CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q”, Haematologica. Pavia, Italy, 90(4), pp. 436-437. doi: 10.3324/%x.